Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

NCT06919159 ·Status: COMPLETED

Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient

NCT05422105 ·Status: UNKNOWN

PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy

NCT06923657 ·Status: RECRUITING ·Phase: NA

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

NCT04742361 ·Status: COMPLETED ·Phase: PHASE3

F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence

NCT04102553 ·Status: COMPLETED ·Phase: PHASE3

Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

NCT06126172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

NCT06612047 ·Status: RECRUITING

The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer

NCT06824259 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer

NCT04487847 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

NCT04298112 ·Status: COMPLETED

PSMA PET Imaging of Recurrent Prostate Cancer

NCT03204123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

NCT05955677 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer

NCT03768349 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer

NCT03122470 ·Status: WITHDRAWN ·Phase: NA

PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer

NCT04983459 ·Status: COMPLETED

Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer

NCT03927287 ·Status: COMPLETED

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

NCT02940977 ·Status: UNKNOWN

PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer

NCT04560725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.

NCT06355843 ·Status: SUSPENDED ·Phase: NA

Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI

NCT04063800 ·Status: COMPLETED

Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients

NCT05819606 ·Status: COMPLETED

The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer

NCT04521894 ·Status: UNKNOWN

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

NCT06862856 ·Status: RECRUITING

PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

NCT05806853 ·Status: COMPLETED ·Phase: PHASE2

PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer

NCT07234981 ·Status: RECRUITING ·Phase: PHASE2